osimertinib
astrazeneca
['adaura', 'nsclc', 'lcsm,(-blcsm)', 'sclc', 'osimertinib']
3. #adaura: ph3, resectable nsclc w/ megfr, adjuvant #osimertinib vs placebo: - approved in 2020
- dfs ib-iiia hr 0.27
- os today stage ib-iiia 5yr os 88% vs 78% (hr 0.49) : what s the right duration? cns surveillance? #lcsm #asco23 4/5 
Practice changing 🗣 for community oncologists: w/ Rohit Gosain @UPMCHillmanCC & Rahul Gosain @WilmotCancer. Views are our own. COI: https://t.co/cJOjp0RvQE